In Q4'25, the latest period covered, total operating expenses for symbol O reached $54.14M USD, entirely attributed to SG&A expenses, as R&D expenses remained at no data across all periods. This reflects a stable but elevated cost base without any R&D allocation. From Q1'23 to Q4'25, SG&A expenses exhibited a clear upward trend, starting at $34.17M USD and increasing to $54.14M USD, with notable growth in Q2'24 ($45.07M USD) and Q3'25 ($55.04M USD), indicating expanding administrative and sales operations. R&D expenses showed no data throughout, suggesting a focus on non-R&D cost drivers in the overall operating expenses, which trended higher by approximately 58% over the three-year span.